Egypt J Med Human Genet 23(1):16
Specifically, 2-OG has been shown to be an agonist of GPR119, a receptor that plays a key role in promoting GLP-1 release in humans
Because they target distinct biological processes, combination therapy theoretically addresses multiple appetite-control points simultaneously
Research has demonstrated their significant potential in energy metabolism, regulating apoptosis and proliferation, and combating fatigue through potent antioxidant, anti-inflammatory, and antibacterial mechanisms, establishing them as a valuable resource pool for developing distinctive functional foods 17,18,19
It is the difference between a real medical practice and the GLP-1 telehealth funnels that have proliferated over the last two years